Efficacy of daratumumab, bortezomib, and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory myeloma based on prior lines of therapy: Updated analysis of castor

Category Primary study
JournalBlood
Year 2016
This article has no abstract
Epistemonikos ID: c56a92ef87c9e0755d0694b1fecdf3bf29af37d5
First added on: Feb 08, 2025